Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3697)
All Articles published online
|
Oct 21, 2005 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang CS, Lin CL, Lee HC, Chen KY, Chiang MF, Chen HS, Lin TJ, Liao LY. Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6115-6119 [PMID: 16273636 DOI: 10.3748/wjg.v11.i39.6115] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i39/6115.htm |
| Number | Citing Articles |
| 1 |
Wen-Chao Wang, Xi-Feng Li, Zhen-Lin Yan, Yu Wang, Jun-Yong Ma, Le-Hua Shi, Xiao-Feng Zhang. Intrahepatic splenosis mimics hepatocellular carcinoma in a patient with chronic hepatitis B. Medicine 2017; 96(47): e8680 doi: 10.1097/MD.0000000000008680
|
| 2 |
Sevil Uygun Ilikhan, Muammer Bilici, Hatice Sahin, Ayşe Semra Demir Akca, Murat Can, Ibrahim Ilker Oz, Berrak Guven, M Cagatay Buyukuysal, Yucel Ustundag. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(22): 6999-7007 doi: 10.3748/wjg.v21.i22.6999
|
| 3 |
Hana Park, Seung Up Kim, Jun Young Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Kwang‐Hyub Han, Jinsil Seong. Clinical usefulness of double biomarkers AFP and PIVKA‐II for subdividing prognostic groups in locally advanced hepatocellular carcinoma. Liver International 2014; 34(2): 313 doi: 10.1111/liv.12274
|
| 4 |
Yoshinori Inagaki, Wei Tang, Masatoshi Makuuchi, Kiyoshi Hasegawa, Yasuhiko Sugawara, Norihiro Kokudo. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des‐γ‐carboxyprothrombin. Liver International 2011; 31(1): 22 doi: 10.1111/j.1478-3231.2010.02348.x
|
| 5 |
Jiaxin Zhang, Guang Chen, Peng Zhang, Jiaying Zhang, Xiaoke Li, Da’nan Gan, Xu Cao, Mei Han, Hongbo Du, Yong’an Ye, Gianfranco D. Alpini. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE 2020; 15(2): e0228857 doi: 10.1371/journal.pone.0228857
|
| 6 |
Ihab Barsoum, Marwan N. Elgohary, Mohamed A.A. Bassiony. Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma. Cancer Biomarkers 2020; 28(4): 523 doi: 10.3233/CBM-190084
|
| 7 |
Patrick Pham, Raphaël Saffroy, Maámar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. Dépistage, diagnostic et suivi biologique du carcinome hépatocellulaire. Revue Francophone des Laboratoires 2006; 2006(387): 73 doi: 10.1016/S1773-035X(06)80501-0
|
| 8 |
Rehan Ali, Yihe Yang, Mark Antkowiak, Ahmed Gabr, Ronald Mora, Nadine Abouchaleh, Ali Al Asadi, Laura Kulik, Daniel Ganger, Michael Abecassis, Nitin Kataraya, Mary Mulcahy, Al Benson, Devalingam Mahalingam, Bartley Thornburg, Samdeep Mouli, Robert J. Lewandowski, Riad Salem, Ahsun Riaz. Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation. CardioVascular and Interventional Radiology 2019; 42(5): 700 doi: 10.1007/s00270-019-02191-z
|
| 9 |
Akpakip I. Ette, Dennis A. Ndububa, Olusegun Adekanle, Udeme Ekrikpo. Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case–control study. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0344-9
|
| 10 |
Fengjie Wan, Yujia Zhu, Feixiang Wu, Xuejing Huang, Ying Chen, Yi Zhou, Hongtao Li, Lifang Liang, Lirong Qin, Qi Wang, Min He. Retinol-binding protein 4 as a promising serum biomarker for the diagnosis and prognosis of hepatocellular Carcinoma. Translational Oncology 2024; 45: 101979 doi: 10.1016/j.tranon.2024.101979
|
| 11 |
Lina Zhao, Jinge Song, Yulin Sun, Qiang Ju, Hong Mu, Xiu Dong, Jing Ding, Yunhe Liu, Xuebing Wang, Liying Sun, Jianxiong Wu, Yuchen Jiao, Shichun Lu, Xiaohang Zhao. Tumor‐derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients. Cancer Medicine 2023; 12(13): 13912 doi: 10.1002/cam4.5946
|
| 12 |
|
| 13 |
Shuji Kanmura, Hirofumi Uto, Yuko Sato, Koutarou Kumagai, Fumisato Sasaki, Akihiro Moriuchi, Makoto Oketani, Akio Ido, Kenji Nagata, Katsuhiro Hayashi, Sherri O. Stuver, Hirohito Tsubouchi. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. Journal of Gastroenterology 2010; 45(4): 459 doi: 10.1007/s00535-009-0160-5
|
| 14 |
Chang-Hun Park, Ja-Young Seo, So Young Kim, Tae Young Jeagal, Eun-Suk Kang. Evaluation of a Modified Enzyme Linked Immunosorbent Assay for Serum PIVKA-II Measurement. Laboratory Medicine Online 2012; 2(2): 87 doi: 10.3343/lmo.2012.2.2.87
|
| 15 |
Ahmed Abdel-Razik, Rania Elhelaly, Rasha Elzehery, Amany El-Diasty, Sally Abed, Dina Elhammady, Ahmed Tawfik. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study. European Journal of Gastroenterology & Hepatology 2016; 28(5): 599 doi: 10.1097/MEG.0000000000000569
|
| 16 |
Honglei Feng, Bole Li, Ze Li, Qian Wei, Li Ren. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08138-3
|
| 17 |
Lvhong Gong, Shengxi Wu, Junjie Liu, Mingjun Zhang, Jinghao Zhuang, Doudou Xu. Construction of an immunosensor based on Cys/Au@TiO2 modification for the detection of liver cancer marker PIVKA-II. Talanta 2024; 275: 126082 doi: 10.1016/j.talanta.2024.126082
|
| 18 |
Hao Xing, Yi-Jie Zheng, Jun Han, Han Zhang, Zhen-Li Li, Wan-Yee Lau, Feng Shen, Tian Yang. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis. Hepatobiliary & Pancreatic Diseases International 2018; 17(6): 487 doi: 10.1016/j.hbpd.2018.09.009
|
| 19 |
Koji Ogawa, Kazuharu Suzuki, Masato Nakai, Takuya Sho, Goki Suda, Kenichi Morikawa, Naoya Sakamoto. Evaluation of clinical utility of PIVKA-II using a chemiluminescent immunoassay. Kanzo 2019; 60(11): 397 doi: 10.2957/kanzo.60.397
|
| 20 |
Jia Fan, Yu Chen, Dan Zhang, Juan Yao, Zijun Zhao, Yao Jiang, Yiqin Li, Yongcan Guo. Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis. Surgical Oncology 2020; 34: 245 doi: 10.1016/j.suronc.2020.05.002
|
| 21 |
Kentaroh Yamamoto, Hiroshi Imamura, Yutaka Matsuyama, Yukio Kume, Hitoshi Ikeda, Gary L. Norman, Zakera Shums, Taku Aoki, Kiyoshi Hasegawa, Yoshifumi Beck, Yasuhiko Sugawara, Norihiro Kokudo. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. Journal of Gastroenterology 2010; 45(12): 1272 doi: 10.1007/s00535-010-0278-5
|
| 22 |
Huaping Chen, Siyuan Chen, Shan Li, Zhijian Chen, Xuan Zhu, Meiyu Dai, Lingxi Kong, Xiaodan Lv, Zhili Huang, Xue Qin. Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study. Oncotarget 2017; 8(52): 90390 doi: 10.18632/oncotarget.20153
|
| 23 |
Rong Zhu, Jing Yang, Ling Xu, Weiqi Dai, Fan Wang, Miao Shen, Yan Zhang, Huawei Zhang, Kan Chen, Ping Cheng, Chengfen Wang, Yuanyuan Zheng, Jingjing Li, Jie Lu, Yingqun Zhou, Dong Wu, Chuanyong Guo. Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis. Gastroenterology Research and Practice 2014; 2014: 1 doi: 10.1155/2014/529314
|
| 24 |
Chapter 2: Diagnosis and surveillance. Hepatology Research 2010; 40(s1): 16 doi: 10.1111/j.1872-034X.2010.00655.x
|
| 25 |
BUI XUAN TRUONG, YOSHIHIKO YANO, VU TUONG VAN, YASUSHI SEO, NGUYEN HOAI NAM, NGUYEN KHANH TRACH, TAKAKO UTSUMI, TAKESHI AZUMA, YOSHITAKE HAYASHI. Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection. Biomedical Reports 2013; 1(1): 122 doi: 10.3892/br.2012.4
|
| 26 |
Bin Hu, Xiaohui Tian, Jie Sun, Xiangjun Meng. Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. International Journal of Molecular Sciences 2013; 14(12): 23559 doi: 10.3390/ijms141223559
|
| 27 |
Keming Zhang, Peipei Song, Jianjun Gao, Gaohua Li, Xin Zhao, Shaogeng Zhang. Perspectives on a combined test of multi serum biomarkers in China: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Drug Discoveries & Therapeutics 2014; 8(3): 102 doi: 10.5582/ddt.2014.01026
|
| 28 |
Darren W. Chua, Ye-Xin Koh, John C. Allen, Chung-Yip Chan, Ser-Yee Lee, Peng-Chung Cheow, Premaraj Jeyaraj, Jin-Yao Teo, Pierce K. Chow, Alexander Y. Chung, London L. Ooi, Brian K.P. Goh. Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: A propensity matched analysis comparing ruptured versus non-ruptured tumors. European Journal of Surgical Oncology 2019; 45(9): 1652 doi: 10.1016/j.ejso.2019.03.044
|
| 29 |
Wesam S. Morad, Ashraf A. Basuni, Tarek Fouad, Hosam A. El Latif, Mohsen Salama, Azza A. El Aziz, Yasser B.D. El Satar, Shimaa Zaki, Nashwa Shebl, Ahmed M. Raouf. The value of PIVKA-II and AFP-L3% in the diagnosis of hepatocellular carcinoma with normal and abnormal AFP levels. Egyptian Liver Journal 2013; 3(1): 1 doi: 10.1097/01.ELX.0000424246.18235.c5
|
| 30 |
Raphaël Saffroy, Patrick Pham, Maâmar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clinical Chemical Laboratory Medicine 2007; 45(9) doi: 10.1515/CCLM.2007.262
|
| 31 |
Kevin Z Qu, Ke Zhang, Wanlong Ma, Hairong Li, Xiuqiang Wang, Xi Zhang, Francis Giles, Michelle Lai, Nezam H Afdhal, Maher Albitar. Ubiquitin‐proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. Journal of Gastroenterology and Hepatology 2011; 26(4): 751 doi: 10.1111/j.1440-1746.2010.06491.x
|
| 32 |
Qianyun Zhang, Qin Xiao, Zhen Lin, Xitang Ying, Zhenjia Li, Jin-Ming Lin. Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma. Clinical Biochemistry 2010; 43(12): 1003 doi: 10.1016/j.clinbiochem.2010.04.074
|
| 33 |
Kentaroh Yamamoto, Hiroshi Imamura, Yutaka Matsuyama, Kiyoshi Hasegawa, Yoshifumi Beck, Yasuhiko Sugawara, Masatoshi Makuuchi, Norihiro Kokudo. Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy. Annals of Surgical Oncology 2009; 16(10): 2795 doi: 10.1245/s10434-009-0618-y
|
| 34 |
Guolin Yuan, Junlin He, Yuan Li, Wailan Xu, Liuliu Gao, Chao Yu. A novel ultrasensitive electrochemical immunosensor based on carboxy-endcapped conductive polypyrrole for the detection of gypican-3 in human serum. Analytical Methods 2015; 7(5): 1745 doi: 10.1039/C4AY02820A
|
| 35 |
Ahsun Riaz, Riad Salem. Laboratory and Imaging Prognostic Indicators following Arterial Locoregional Therapies for Hepatocellular Carcinoma Survival. Journal of Vascular and Interventional Radiology 2019; 30(12): 1893 doi: 10.1016/j.jvir.2019.09.003
|
| 36 |
Ranjit Chauhan, Nivedita Lahiri. Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomarkers in Cancer 2016; : BIC.S34413 doi: 10.4137/BIC.S34413
|
| 37 |
Rentao Yu, Xiaomei Xiang, Zhaoxia Tan, Yi Zhou, Haoliang Wang, Guohong Deng. Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients. Scientific Reports 2016; 6(1) doi: 10.1038/srep35050
|
| 38 |
Shuji Kanmura, Hirofumi Uto, Kazunori Kusumoto, Yoichi Ishida, Satoru Hasuike, Kenji Nagata, Katsuhiro Hayashi, Akio Ido, Sherri Oliver Stuver, Hirohito Tsubouchi. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system†. Hepatology 2007; 45(4): 948 doi: 10.1002/hep.21598
|
| 39 |
Yi‐Jun Qi, Douglas G. Ward, Chun Pang, Qi‐Ming Wang, Wenbin Wei, Jin Ma, Juan Zhang, Qiang Lou, Neil J. Shimwell, Ashley Martin, Nathalie Wong, Wei‐Xia Chao, Ming Wang, Yuan‐Fang Ma, Philip J. Johnson. Proteomic profiling of N‐linked glycoproteins identifies ConA‐binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma. PROTEOMICS 2014; 14(2-3): 186 doi: 10.1002/pmic.201300226
|
| 40 |
Feng Ding, Kehuan Sun, Ningning Sun, Qianqian Jiang, Meiqun Cao, Zhengzhi Wu. iTRAQ-based proteomics reveals SOD2 as a potential salivary biomarker in liver cancer. The International Journal of Biological Markers 2019; 34(3): 221 doi: 10.1177/1724600819841619
|
| 41 |
Ji De, Yi Shen, Jinyu Qin, Li Feng, Yiping Wang, Li Yang. A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma. Medicine 2016; 95(17): e3448 doi: 10.1097/MD.0000000000003448
|
| 42 |
YAN-JIE ZHAO, QIANG JU, GUAN-CHENG LI. Tumor markers for hepatocellular carcinoma. Molecular and Clinical Oncology 2013; 1(4): 593 doi: 10.3892/mco.2013.119
|
| 43 |
Ghazaleh Pourali, Yasamin Rajabloo, Nayyerehalsadat Hosseini, Mina Maftooh, Majid Ghayour-Mobarhan, Saman Soleimanpour, Seyed Mahdi Hassanian, Gordon A. Ferns, Mohammad Ali Kiani, Majid Khazaei, Amir Avan. Biomaterials for Precision Cancer Medicine. 2025; : 27 doi: 10.1016/B978-0-323-85661-4.00006-8
|
| 44 |
Ahmed M. Tahon, Magdy Z. El-Ghanam, Samy Zaky, Tarek Mostafa Emran, Ali M. Bersy, Fathiya El-Raey, Elsayed A.Z., Amr M. El Kharsawy, Dina Johar. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients. Journal of Gastrointestinal Cancer 2019; 50(3): 434 doi: 10.1007/s12029-018-0095-2
|
| 45 |
Yibo Wang, Fang Luo, Yi Zheng, Xiaohan Fan, Jinxing Chen, Yu Zhang, Rutai Hui.
VKORC1 haplotypes influence the performance characteristics of PIVKAII for screening of hepatocellular carcinoma. cclm 2010; 48(10): 1475 doi: 10.1515/CCLM.2010.275
|
| 46 |
Mohammed El Fayoumie, Mahmoud Abdelhady, Ahmed Gawish, Usama Hantour, Ismail Abdelkhaleek, Mohamed Abdelraheem, Alaa Alsawak, Ahmed Alwassief, Ashraf Elbahrawy. Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents. Gastrointestinal Tumors 2020; 7(1-2): 50 doi: 10.1159/000505326
|
| 47 |
Michele Malaguarnera, Marco Vacante, Rosangela Fichera, Alessandro Cappellani, Erika Cristaldi, Massimo Motta. Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients. Archives of Gerontology and Geriatrics 2010; 51(1): 81 doi: 10.1016/j.archger.2009.08.004
|
| 48 |
Kazuaki Tabu, Seiichi Mawatari, Kohei Oda, Ohki Taniyama, Ai Toyodome, Sho Ijuin, Haruka Sakae, Kotaro Kumagai, Shuji Kanmura, Akio Ido. Highly sensitive Lens culinaris agglutinin‑reactive fraction of α‑fetoprotein is a predictive marker for hepatocarcinogenesis in long‑term observation of patients with chronic liver disease. Molecular and Clinical Oncology 2021; 15(3) doi: 10.3892/mco.2021.2336
|
| 49 |
Lina Zhao, Zhifa Zheng, Yunhe Liu, Fei Liu, Xiaoxin Li, Zhihong Wu. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(9): 6035 doi: 10.1007/s00432-022-04526-9
|
| 50 |
Brian I. Carr, Petr Pancoska, Robert A. Branch. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatology International 2010; 4(1): 396 doi: 10.1007/s12072-009-9157-7
|
| 51 |
Isao Yamaguchi, Kenji Nakamura, Hiromichi Kitano, Yoshie Masuda, Futoshi Kanke, Shinzo Kobatake, Shinji Satomura. Development of des-γ-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer. Clinical Chemical Laboratory Medicine 2008; 46(3) doi: 10.1515/CCLM.2008.078
|
| 52 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
| 53 |
Rasha Elzehery, Narmin Effat, Reham El Farahaty, Raghda Elsayed Farag, Ekbal M Abo-Hashem, Rania Elhelaly. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 158(2): 254 doi: 10.1093/ajcp/aqac037
|
| 54 |
Atsushi Nanashima, Naota Taura, Takafumi Abo, Tatsuki Ichikawa, Ichiro Sakamoto, Takeshi Nagayasu, Kazuhiko Nakao. Tumor Marker Levels Before and After Curative Treatment of Hepatocellular Carcinoma as Predictors of Patient Survival. Digestive Diseases and Sciences 2011; 56(10): 3086 doi: 10.1007/s10620-011-1796-6
|
| 55 |
Rong Liu, Ming-Ping Qian, Ying-Yu Cui. Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma. Metabolism 2023; 147: 155665 doi: 10.1016/j.metabol.2023.155665
|
| 56 |
Changzai Li, Zhiming Zhang, Pan Zhang, Jianyong Liu. Diagnostic accuracy of des‐gamma‐carboxy prothrombin versus α‐fetoprotein for hepatocellular carcinoma: A systematic review. Hepatology Research 2014; 44(10) doi: 10.1111/hepr.12201
|
| 57 |
Kewal K. Jain. Applications of Biotechnology in Oncology. 2014; : 87 doi: 10.1007/978-1-4614-9245-0_5
|
| 58 |
M.-S. Park, K.-W. Lee, H. Kim, Y.R. Choi, G. Hong, N.-J. Yi, K.-S. Suh. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma. Transplantation Proceedings 2017; 49(5): 1109 doi: 10.1016/j.transproceed.2017.03.017
|
| 59 |
Brian I Carr, Shama C Buch, Venkateswarlu Kondragunta, Petr Pancoska, Robert A Branch. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: A case cohort study. Journal of Gastroenterology and Hepatology 2008; 23(8pt1): 1259 doi: 10.1111/j.1440-1746.2008.05487.x
|
| 60 |
Jonghyeon Choi, Yongjung Park, Jeong-Ho Kim, Hyon-Suk Kim. Evaluation of automated serum des-gamma-carboxyprothrombin (DCP) assays for detecting hepatocellular carcinoma. Clinical Biochemistry 2011; 44(17-18): 1464 doi: 10.1016/j.clinbiochem.2011.08.1144
|
| 61 |
Lorinda M. Wright, Jeff T. Kreikemeier, Claus J. Fimmel. A concise review of serum markers for hepatocellular cancer. Cancer Detection and Prevention 2007; 31(1): 35 doi: 10.1016/j.cdp.2006.11.003
|
| 62 |
Surachate Siripongsakun, Sindy H Wei, Stephanie Lin, Jeffrey Chen, Steven S Raman, James Sayre, Myron J Tong, David S Lu. Evaluation of alpha‐fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation. Journal of Gastroenterology and Hepatology 2014; 29(1): 157 doi: 10.1111/jgh.12438
|
| 63 |
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly. Novel biomarkers in hepatocellular carcinoma. Digestive and Liver Disease 2018; 50(11): 1115 doi: 10.1016/j.dld.2018.08.019
|
| 64 |
Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatology International 2010; 4(2): 439 doi: 10.1007/s12072-010-9165-7
|
| 65 |
Darren W Chua, Ye Xin KOH, Yi Xin LIEW, Chung‐Yip Chan, Ser‐Yee Lee, Peng‐Chung Cheow, Pierce K Chow, Alexander Y Chung, London L Ooi, Brian KP Goh. Pre‐operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma. Journal of Surgical Oncology 2018; 118(8): 1227 doi: 10.1002/jso.25281
|
| 66 |
Xueying Wang, Yangyu Zhang, Na Yang, Hua He, Xuerong Tao, Changgui Kou, Jing Jiang. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5087643
|
| 67 |
Yoshinori Inagaki, Fanghua Qi, Jianjun Gao, Xianjun Qu, Kiyoshi Hasegawa, Yasuhiko Sugawara, Wei Tang, Norihiro Kokudo. Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth. BioScience Trends 2011; 5(2): 52 doi: 10.5582/bst.2011.v5.2.52
|
| 68 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 69 |
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2018; 18(8): 713 doi: 10.1080/14737159.2018.1496020
|
| 70 |
Qianyun Zhang, Xu Wang, Zhenjia Li, Jin-Ming Lin. Evaluation of α-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases. Analytica Chimica Acta 2009; 631(2): 212 doi: 10.1016/j.aca.2008.10.042
|
| 71 |
|